CDW vs TGTX · P/E 22, rev $12.25B vs P/E 18, rev $240.3M
CDW Corp (CDW) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported CDW revenue for 2026-06-30 was $12.25B. Net income was $509.8M. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the CDW and TGTX stock pages for the full models.
Not investment advice.